Abstract:Nitric oxide-releasing nonsteroidal anti-inflammatory drugs (NO-NSAID) are promising chemoprevention agents; unlike conventional NSAIDs, they seem free of appreciable adverse effects, while they retain beneficial activities of their parent compounds. Their effect on colon carcinogenesis using carcinoma formation as an end point is unknown. We assessed the chemopreventive properties of NO-indomethacin (NCX 530) and NO-aspirin (NCX 4016) against azoxymethane-induced colon cancer. Seven-week-old male F344 rats were fed control diet, and 1 week later, rats received two weekly s.c. injections of azoxymethane (15 mg/kg body weight). Two weeks after azoxymethane treatment, rats (48 per group) were fed experimental diets containing NO-indomethacin (0, 40, or 80 ppm), or NO-aspirin (1,500 or 3,000 ppm), representing 40% and 80% of the maximum tolerated dose. All rats were killed 48 weeks after azoxymethane treatment and assessed for colon tumor efficacy and molecular changes in colonic tumors and normally appearing colonic mucosa of different dietary groups. Our results suggest that NO-indomethacin at 40 and 80 ppm and NO-aspirin at 3,000 ppm significantly suppressed both tumor incidence (P < 0.01) and multiplicity (P < 0.001). The degree of inhibition was more pronounced with NO-indomethacin at both dose levels (72% and 76% inhibition) than with NO-aspirin (43% and 67%). NO-indomethacin at 40 and 80 ppm and NO-aspirin at 3,000 ppm significantly inhibited the colon tumors' (P < 0.01 to P < 0.001) total cyclooxygenase (COX), including COX-2 activity (52-75% inhibition) and formation of prostaglandin E2 (PGE2), PGF2alpha, and 6-keto-PGF1alpha, and TxB2 from arachidonic acid (53-77% inhibition). Nitric oxide synthase 2 (NOS-2) activity and beta-catenin expression were suppressed in animals given NO-NSAID. In colonic crypts and tumors of animals fed these two NO-NSAIDs, there was a significant decrease in proliferating cell nuclear antigen labeling when compared with animals fed the control diet. The results of this study provide strong evidence that NO-NSAIDs possess strong inhibitory effect against colon carcinogenesis; their effect is associated with suppression of COX and NOS-2 activities and beta-catenin levels in colon tumors. These results pave the way for the rational design of human clinical trials.

[Induction of NAG-1 Gene Expression in Colon Cancer Cells by Non-Steroidal Anti-Inflammatory Drugs].

Cyclooxygenase-Independent Effects of Aspirin on Ht-29 Human Colon Cancer Cells, Revealed by Oligonucleotide Microarrays

Effects of nonsteroidal anti-inflamm atory drugs on the proliferation and cyclooxygenase activity of gastric cancer cell line SGC7901

Nitric oxide-releasing aspirin and indomethacin are potent inhibitors against colon cancer in azoxymethane-treated rats: effects on molecular targets

NSAIDs Induced Apoptosis of Gastric Cancer Cell Lines and the Mechanism

The inhibitory effect of nonsteroid anti-inflammatory drugs on gastric cancer

Nicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induce cyclooxygenase-2 activity in human gastric cancer cells: Involvement of nicotinic acetylcholine receptor (nAChR) and β-adrenergic receptor signaling pathways

The COX-2 Selective Inhibitor-Independent COX-2 Effect on Colon Carcinoma Cells is Associated with the Delta1/Notch1 Pathway

[Effects of Selective and Non-Selective Cyclooxygenase-2 Inhibitor on the Growth of Colon Cancer Cells].

[Celecoxib Inhibits Gastric Adenocarcinoma Growth Via Inducing Expression of Human Nonsteroidal Anti-Inflammatory Drug Activated Gene].

Nitric Oxide-donating NSAIDs in Chemoprevention of Colon Cancer

Inhibition of angiogenesis in cancer by iNOS antisense oligodeoxynucleotide

Molecular investigation of the direct anti-tumour effects of nonsteroidal anti-inflammatory drugs in a panel of canine cancer cell lines

Inhibitory effect of nimesulide on the development of N-ethyl-N-nitro-N-nitrosoguanidine-induced gastric precancerous lesions in rats

Regulation of non-steroidal anti-inflammatory drugs on apoptosis and apoptosis related genes of gastric cancer cell line

Synergistic Effect of Indomethacin and NGX6 on Proliferation and Invasion by Human Colorectal Cancer Cells Through Modulation of the Wnt/β-catenin Signaling Pathway

Effects of NS398, an inhibitor of cyclooxygenase 2, on the growth and apoptosis of human squamous cell carcinoma cell line Tca8113

[Effects of NaBT and NSAIDs on Colorectal Adenoma-Carcinoma Cells].

Indomethacin Induces Gastric Cancer Cell Apoptosis Through Akt/GSK3β/NAG-1 Pathway

Non-steroidal anti-inflammatory drugs induce immunogenic cell death in suppressing colorectal tumorigenesis

Research about NS-398 Inhibiting Rat Colon Cancer